Fluconazole
In clinical developmentAlso known as Diflucan, Difluconazole, Fluconazol, Fluconazolum.
Recent clinical, regulatory, research and industry developments relating to this drug.
Evaluation of CrAg Screening With Enhanced Antifungal Therapy for Asymptomatic CrAg+ Persons
The Drug-Drug Interaction Study of Clifutinib
Profile
Canonical identifiers, marketed brand names and mechanism, resolved across RxNorm, ChEMBL and ATC.
Clinical trials
The current development programme across all trial phases — status mix, phase distribution and the late-stage studies shaping the evidence base.
Late-stage studies
Phase III+ trials still open or recently active — where late-stage evidence is being generated.
Recent completions
Trials that read out recently, adding to the completed evidence base.
Research activity
Key research shaping understanding of this drug, combining the latest publications with the most influential evidence.
Journals, researchers & institutions
- Medical mycology1
- Mycoses1
- Fan S2
- Li T2
- Liang Y2
- Liu X2
- Zhu Y2
- Guo X1
- Xu H1
- Zhou X1
- Department of Laboratory Science2
- Peking University Shenzhen Hospital2
- Postgraduate College1
- Shenzhen Key Laboratory of Gynaecological Diagnostic Technology Research1
- RxNorm (U.S. National Library of Medicine) — drug identity
- ChEMBL (EMBL-EBI) & UniProt — pharmacology and targets
- Europe PMC — research literature
- ClinicalTrials.gov — clinical trials